Japanese guidelines for the management of stroke 2009 - Important revised points necessary for the neurologist

Clinical Neurology

Volumn 50, Issue 11, 2010, Pages 808-811

  Shinohara, Yukito ^a  

^a Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

Author keywords

External review of the guidelines; Guidelines; Secondary stroke prevention; Stroke; Stroke therapy in acute stage

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; CONFERENCE PAPER; HUMAN; NEUROLOGIST; PRACTICE GUIDELINE; STROKE;

ASPIRIN; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; EVIDENCE-BASED MEDICINE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; JAPAN; NEUROLOGY; PHYSICIANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PYRROLES; RECURRENCE; STROKE; TETRAZOLES; THIAZOLIDINEDIONES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856399243     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.50.808     Document Type: Conference Paper

References (10)

1. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-1905. (Pubitemid 29242803)
2. Shinohara Y, Nagayama M, Origasa H. Postpublication external review of the Japanese guidelines for the management of stroke 2004. Stroke 2009;40:1439-1443.
3. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
4. Dormandy JA, Charbonnel B, Eckland DJA, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial macroVascular Events): a randomised controlled trial. Lancet 2005;366:1279-1289. (Pubitemid 41416583)
5. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559. (Pubitemid 44202151)
6. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 2008;39:2052-2058.
7. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1439-1501.